WASHINGTON — For all the unpredictability of President Trump’s second administration, he has turned one expression of chaos into a ritual so consistent that Washington can set its collective ...

Big pharma's interest in using protein degradation as a therapeutic strategy continues with a wide-ranging deal between Pfizer and US biotech Triana Biomedicines that could be worth $1.5 billion ...

WASHINGTON — When President Trump and his supporters talk about draining the “swamp” of the federal government bureaucracy, they probably don’t have Kansas City in mind. But with Trump’s ...